Unihealth Consultancy Share Price
Start SIP in Unihealth Consultancy
Start SIPUnihealth Consultancy Performance
Day Range
- Low 150
- High 150
52 Week Range
- Low 109
- High 176
- Open Price150
- Previous Close150
- Volume5000
Unihealth Consultancy Investment Rating
-
Master Rating:
-
Unihealth Consultancy Ltd has an operating revenue of Rs. 155.73 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 28% is great, ROE of 12% is good. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 14% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -9% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 102 indicates it belongs to a poor industry group of Medical-Managed Care and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2024 | Mar 2023 |
|---|---|---|
| Total Revenue Annual Cr | 7 | 4 |
| Operating Expenses Annual Cr | 2 | 1 |
| Operating Profit Annual in Cr | 2 | 1 |
| Depreciation Cr | 0 | 0 |
| Interest Annual Cr | 0 | 1 |
| Tax Annual Cr | 1 | 0 |
| Net Profit Annual Cr | 3 | 1 |
Unihealth Consultancy Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 10
- Bearish Moving Average
- ___
- 6
- 20 Day
- ₹148.29
- 50 Day
- ₹138.52
- 100 Day
- ₹133.95
- 200 Day
- ₹134.63
- 20 Day
- ₹150.03
- 50 Day
- ₹133.50
- 100 Day
- ₹129.09
- 200 Day
- ₹134.07
Unihealth Consultancy Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 150.00 |
| Second Resistance | 150.00 |
| Third Resistance | 150.00 |
| RSI | 54.96 |
| MFI | 61.93 |
| MACD Single Line | 7.54 |
| MACD | 6.28 |
| Support | |
|---|---|
| First Support | 150.00 |
| Second Support | 150.00 |
| Third Supoort | 150.00 |
Unihealth Consultancy Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 5,000 | 500,000 | 100 |
| Week | 16,000 | 1,240,000 | 77.5 |
| 1 Month | 49,227 | 3,904,707 | 79.32 |
| 6 Month | 22,065 | 1,900,021 | 86.11 |
Unihealth Consultancy Result Highlights
Unihealth Consultancy Synopsis
NSE-Medical-Managed Care
Unihealth Consultanc belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 4.23 Cr. and Equity Capital is Rs. 15.40 Cr. for the Year ended 31/03/2024. Unihealth Consultancy Ltd. is a Public Limited Listed company incorporated on 26/02/2010 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U85100MH2010PLC200491 and registration number is 200491.| Market Cap | 231 |
| Sales | 4 |
| Shares in Float | 0.48 |
| No of funds | 2 |
| Yield |
| Book Value | 3.58 |
| U/D Vol ratio | 2.1 |
| LTDebt / Equity | 5 |
| Alpha | |
| Beta | 0.71 |
Unihealth Consultancy Shareholding Pattern
| Owner Name | Mar-24 | Sep-23 |
|---|---|---|
| Promoters | 68.8% | 68.8% |
| Insurance Companies | 0.12% | 0.12% |
| Foreign Portfolio Investors | 5.61% | |
| Financial Institutions/ Banks | 0.02% | 0.23% |
| Individual Investors | 23.82% | 15.98% |
| Others | 7.24% | 9.26% |
Unihealth Consultancy Management
| Name | Designation |
|---|---|
| Dr. Akshay M Parmar | Chairman & Managing Director |
| Mr. Parag Shah | Executive Director |
| Dr. Anurag Shah | Director |
| Mr. Ajay Kumar Thakur | Independent Director |
| Mrs. Riddhi Javeri | Independent Director |
Unihealth Consultancy Forecast
Price Estimates
Unihealth Consultancy Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-23 | Audited Results | |
| 2023-11-08 | Quarterly Results |
Unihealth Consultancy FAQs
What is Share Price of Unihealth Consultancy ?
Unihealth Consultancy share price is ₹150 As on 18 September, 2024 | 02:31
What is the Market Cap of Unihealth Consultancy ?
The Market Cap of Unihealth Consultancy is ₹231 Cr As on 18 September, 2024 | 02:31
What is the P/E ratio of Unihealth Consultancy ?
The P/E ratio of Unihealth Consultancy is As on 18 September, 2024 | 02:31
What is the PB ratio of Unihealth Consultancy ?
The PB ratio of Unihealth Consultancy is 2.7 As on 18 September, 2024 | 02:31